Drug intelligence / Profile preview

peste des petits ruminants vaccine

Development stage
Unknown
Lead developer
Kemin Industries
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

The Peste des Petits Ruminants (PPR) vaccine developed by Middle East for Vaccines (MEVAC) is a veterinary vaccine indicated for the active immunization of small ruminants, specifically sheep and goats, against the Peste des Petits Ruminants virus (PPRV). PPR, also known as 'goat plague,' is a highly contagious viral disease characterized by severe pneumonia, fever, and mucosal erosions. The vaccine is a live-attenuated formulation, typically utilizing the Nigeria 75/1 strain, which is the international standard for PPR vaccination. It works by stimulating a robust and long-lasting immune response, providing protection against clinical disease and reducing viral shedding. This vaccine is a critical component of regional and global efforts to control and eventually eradicate PPR in endemic areas.

Brand names
MEVAC PPR
Other names
Peste des Petits Ruminants VaccinePPR vaccine

Beyond the preview

Go deeper on peste des petits ruminants vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peste des petits ruminants vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call